With this month’s acquisitions of an additional domestic manufacturing facility and an FDA-registered packaging and blending facility, infant formula company ByHeart successfully consolidated its ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

US infant formula manufacturer ByHeart has acquired its third facility, tripling production capacity to supply the struggling US market. The New York-based company said the acquisition gave it “full ...

Abbott plans to build a $500 million infant formula facility and is boosting production at other plants as the health care company looks to increase supply in the U.S. amid ongoing shortages. "We're ...

Constraints on the U.S. defense industrial base and concerns about limited manufacturing capacity have been ascribed to a production approach described as “just-in-time.” Just-in-time production has ...